A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
Clinical trial NCT00449176 · COMPLETED
Trial details
- NCT number
- NCT00449176
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-05-01
- Enrollment
- 981
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.